Top Markets
#1 PulseChain PulseChain +45.13%
#2 Bitway Bitway +9.31%
#3 Fake World Assets Fake World Assets +9.25%
#4 eCash eCash +7.18%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.83%
#6 Meteora Meteora +6.82%
#7 Qkacoin Qkacoin +6.49%
#8 EthereumPoW EthereumPoW +5.88%
#9 Bitcoin SV Bitcoin SV +5.69%
#10 Velvet Velvet +5.58%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
AgeX Therapeutics, Inc. AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc.

AGE
Rank in Stocks #28235
AgeX Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to... AgeX Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to pioneering and commercializing groundbreaking therapies that address human aging and degenerative conditions. The company's developmental pipeline features several promising cell-based therapeutic candidates: AGEX-BAT1: A cell therapy designed to manage various age-related metabolic disorders, including adult-onset Type II diabetes and obesity. AGEX-VASC1: A cell-based approach aimed at re-establishing vital vascular support in aged ischemic tissues, which could be relevant for conditions such as peripheral vascular disease and ischemic heart disease. Beyond cell therapies, AgeX is also exploring other modalities: Its primary drug candidate in the discovery phase is AGEX-iTR1547, a drug formulation focused on achieving scarless wound repair. For induced tissue regeneration, its leading biologic candidate is AGEX-iTR1550, which leverages gene delivery technology. Furthermore, AgeX maintains a research collaboration with the University of California at Irvine, jointly working to develop cellular therapies for various neurological disorders. Founded in 2017, AgeX Therapeutics, Inc. maintains its headquarters in Alameda, California.
Share Price
$11.10
Last synced: 2024-03-26
Market Cap
$27.76M
Change (1 day)
-11.90%
Change (1 year)
0.00%
Country
US
Trade AgeX Therapeutics, Inc. (AGE)

Category

Healthcare
Operating Margin for AgeX Therapeutics, Inc. (AGE)
Operating Margin as of 2026 TTM: 0.00%
According to AgeX Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for AgeX Therapeutics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.